APA (7th ed.) Citation

Etikasari, R., Andayani, T. M., Endarti, D., & Taroeno-Hariadi, K. W. (2023). The 5-Year Disease-Free Survival of Third Generation Aromatase Inhibitor for Postmenopausal Women with HR-positive HER2-negative Non-Metastatic Breast Cancer. International Journal of Hematology-Oncology & Stem Cell Research, 17(1), 48.

Chicago Style (17th ed.) Citation

Etikasari, Ria, Tri Murti Andayani, Dwi Endarti, and Kartika Widayati Taroeno-Hariadi. "The 5-Year Disease-Free Survival of Third Generation Aromatase Inhibitor for Postmenopausal Women with HR-positive HER2-negative Non-Metastatic Breast Cancer." International Journal of Hematology-Oncology & Stem Cell Research 17, no. 1 (2023): 48.

MLA (9th ed.) Citation

Etikasari, Ria, et al. "The 5-Year Disease-Free Survival of Third Generation Aromatase Inhibitor for Postmenopausal Women with HR-positive HER2-negative Non-Metastatic Breast Cancer." International Journal of Hematology-Oncology & Stem Cell Research, vol. 17, no. 1, 2023, p. 48.